Heterotic expression in inbreds derived from four different base populations in maize (Zea mays L.).

The concepts of combining ability and heterosis are the fundamental tools for enhancing productivity of different crops. The main objective is to study the usefulness of inbreds derived from four different base populations namely advanced generations of single cross hybrids, three way cross hybrids, hybrid mixtures and composites by analyzing the combining ability of inbreds and crosses derived and the heterosis obtained for important characters. One hundred and forty four maize inbreds derived from four different base populations namely advanced generations of single cross hybrids, three way cross hybrids, hybrid mixtures and composites were studied for their heterotic expression. The results indicated that composite and hybrid mixture base populations shall be of great use in deriving genetically divergent inbreds and single cross hybrids with significant standard heterosis suitable for commercial exploitation

Evaluating tropical single cross maize hybrids for adaptability and commercial value

Stability analysis was carried out to study stability in performance and genotype x environment interactions for sixty single cross hybrids along with three checks viz., 900M Gold, CP 818 and NK 6240 in three research farms of Foliage Crop Solutions Private Limited viz., Attur (Tamilnadu), Hosur (Tamilnadu), and Renebennur (Karnataka) un- der irrigated conditions during 2011-13. Data were recorded on different morphological and yield parameters viz., days to 50% silking, days to maturity, plant height, number of leaves, ear length, number of kernels row-1, number of kernels ear-1, hundred seed weight, and grain yield and the mean was used for statistical analysis. Analysis of variance carried out for all the characters revealed that the variance due to genotypes was highly significant for all the characters studied in all the three environments. Pooled analysis of variance for stability done using Eber- hart and Russel model of stability revealed that the variance due to genotypes, environments and environment components were highly significant for all the characters studied. However, it was found that the variance due to genotype x environment (linear) component was non-significant only for ear length and number of kernel rows and significant for the remaining characters

Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience

Objective: To assess the influence of the 2012 US Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen (PSA)-based screening on oncological and functional outcomes following robot-assisted laparoscopic prostatectomy (RALP). Materials and Methods: We retrospectively analysed patients who underwent RALP between 2008 and 2018 with a minimum of 12-month follow-up from a prospectively collected institutional review board-approved database. The impact of the USPSTF recommendation against PSA screening on our surgical outcomes was assessed using a logistic regression model using two groups comprising patients treated before/after the USPSTF statement and indicating time trends for each successive year. Results: The mean preoperative PSA increased from 6.0 to 7.4 ng/mL after the USPSTF recommendation. We detected statistically significant time-trend changes after 2012, including an increase in the positive slope of Gleason ≥3 + 4 or ≥pT3 disease. We detected a fall in bilateral full nerve-sparing and an increase in partial nerve-sparing. The total positive surgical margin (PSM) rate increased after the USPSTF recommendation; however, PSM rates pertinent to each pathological stage did not change significantly after 2012. There was a significant negative trend change in the postoperative 12-month continence and potency rates, indicating a breakpoint in functional outcomes after 2012. We detected a 1.7-fold increase in 12-month biochemical recurrence (BCR) rates. The 12-month BCR, potency and continence rates were maintained in young (<55 years) patients with a Sexual Health Inventory for Men score >22 and low-volume disease. Conclusion: Since the USPSTF’s recommendation in 2012, we have seen a significant increase in the incidence of high-risk disease that has forced us to modify our approach to the procedure and the grade of nerve-sparing used, leading to a wider resection, in order to reduce PSMs. This has led to a decrease in postoperative functional recovery. Patients with favourable characteristics had good outcomes before and after the USPSTF’s recommendation, implying that the quality of surgery did not change over time

Climate change impacts and potential benefits of heat-tolerant maize in South Asia

Article Purchased; Published online: 14 September 2016Maize is grown by millions of smallholder farmers in South Asia (SA) under diverse environments. The crop is grown in different seasons in a year with varying exposure to weather extremes, including high temperatures at critical growth stages which are expected to increase with climate change. This study assesses the impact of current and future heat stress on maize and the benefit of heat-tolerant varieties in SA. Annual mean maximum temperatures may increase by 1.4–1.8 °C in 2030 and 2.1–2.6 °C in 2050, with large monthly, seasonal, and spatial variations across SA. The extent of heat stressed areas in SA could increase by up to 12 % in 2030 and 21 % in 2050 relative to the baseline. The impact of heat stress and the benefit from heat-tolerant varieties vary with the level of temperature increase and planting season. At a regional scale, climate change would reduce rainfed maize yield by an average of 3.3–6.4 % in 2030 and 5.2–12.2 % in 2050 and irrigated yield by 3–8 % in 2030 and 5–14 % in 2050 if current varieties were grown under the future climate. Under projected climate, heat-tolerant varieties could minimize yield loss (relative to current maize varieties) by up to 36 and 93 % in 2030 and 33 and 86 % in 2050 under rainfed and irrigated conditions, respectively. Heat-tolerant maize varieties, therefore, have the potential to shield maize farmers from severe yield loss due to heat stress and help them adapt to climate change impacts

Non-conventional therapeutics for oral infections

© 2015 Robert P Allaker and CW Ian Douglas. As our knowledge of host-microbial interactions within the oral cavity increases, future treatments are likely to be more targeted. For example, efforts to target a single species or key virulence factors that they produce, while maintaining the natural balance of the resident oral microbiota that acts to modulate the host immune response would be an advantage. Targeted approaches may be directed at the blackpigmented anaerobes, Porphyromonas gingivalis and Prevotella intermedia, associated with periodontitis. Such pigments provide an opportunity for targeted phototherapy with high-intensity monochromatic light. Functional inhibition approaches, including the use of enzyme inhibitors, are also being explored to control periodontitis. More general disruption of dental plaque through the use of enzymes and detergents, alone and in combination, shows much promise. The use of probiotics and prebiotics to improve gastrointestinal health has now led to an interest in using these approaches to control oral disease. More recently the potential of antimicrobial peptides and nanotechnology, through the application of nanoparticles with biocidal, antiadhesive and delivery capabilities, has been explored. The aim of this review is to consider the current status as regards non-conventional treatment approaches for oral infections with particular emphasis on the plaque-related diseases

Paget's disease of the breast in a male with lymphomatoid papulosis: a case report

<p>Abstract</p> <p>Introduction</p> <p>Paget's disease is an eczematous skin change of the nipple that is usually associated with an underlying breast malignancy. Male breast cancer represents only 1-3% of all breast malignancies and Paget's disease remains very rare.</p> <p>Case presentation</p> <p>We present the case of a 67-year-old Caucasian man with lymphomatoid papulosis who was diagnosed with Paget's disease of the nipple and who was treated successfully with surgery alone. We discuss the presentation, investigations, management and pathogenesis of Paget's disease of the nipple.</p> <p>Conclusion</p> <p>The case highlights the need to be vigilant when new skin lesions arise in the context of an underlying chronic skin disorder.</p

Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States

BACKGROUND: Outcomes data regarding advanced synovial sarcoma (SS) and myxoid/round cell liposarcoma (MRCL) are limited, consisting primarily of retrospective series and post hoc analyses of clinical trials. METHODS: In this multi-center retrospective study, data were abstracted from the medical records of 350 patients from nine sarcoma centers throughout the United States and combined into a registry. Patients with advanced/unresectable or metastatic SS (n = 249) or MRCL (n = 101) who received first-line systemic anticancer therapy and had records of tumor imaging were included. Overall survival (OS), time to next treatment, time to distant metastasis, and progression-free survival (PFS) were evaluated using the Kaplan-Meier method and Cox regression. RESULTS: At start of first-line systemic anticancer therapy, 92.4% of patients with SS and 91.1% of patients with MRCL had metastatic lesions. However, 74.7% of patients with SS and 72.3% of patients with MRCL had ≥2 lines of systemic therapy. Median OS and median PFS from first-line therapy for SS was 24.7 months (95% CI, 20.9-29.4) and 7.5 months, respectively (95% CI, 6.4-8.4). Median OS and median PFS from start of first-line therapy for MRCL was 29.9 months (95% CI, 27-44.6) and 8.9 months (95% CI 4.5-12.0). CONCLUSIONS: To the best of our knowledge, this is the largest retrospective study of patients with SS and MRCL. It provides an analysis of real-world clinical outcomes among patients treated at major sarcoma cancer centers and could inform treatment decisions and design of clinical trials. In general, the survival outcomes for this selected population appear more favorable than in published literature